Literature DB >> 22306812

Oxidative stress increases BACE1 protein levels through activation of the PKR-eIF2α pathway.

François Mouton-Liger1, Claire Paquet, Julien Dumurgier, Constantin Bouras, Laurent Pradier, Françoise Gray, Jacques Hugon.   

Abstract

Beta-site APP cleaving enzyme 1 (BACE1) is the rate limiting enzyme for accumulation of amyloid β (Aβ)-peptide in the brain in Alzheimer's disease (AD). Oxidative stress (OS) that leads to metabolic dysfunction and apoptosis of neurons in AD enhances BACE1 expression and activity. The activation of c-jun N-terminal kinase (JNK) pathway was proposed to explain the BACE1 mRNA increase under OS. However, little is known about the translational control of BACE1 in OS. Recently, a post-transcriptional increase of BACE1 level controlled by phosphorylation of eIF2α (eukaryotic translation initiation factor-2α) have been described after energy deprivation. PKR (double-stranded RNA dependant protein kinase) is a pro-apoptotic kinase that phosphorylates eIF2α and modulates JNK activation in various cellular stresses. We investigated the relations between PKR, eIF2α and BACE1 in AD brains in APP/PS1 knock-in mice and in hydrogen peroxide-induced OS in human neuroblastoma (SH-SY5Y) cell cultures. Immunoblotting results showed that activated PKR (pPKR) and activated eIF2α (peIF2α) and BACE1 levels are increased in AD cortices and BACE1 correlate with phosphorylated eIF2α levels. BACE1 protein levels are increased in response to OS in SH-SY5Y cells and specific inhibitions of PKR-eIF2α attenuate BACE1 protein levels in this model. Our findings provide a new translational regulation of BACE1, under the control of PKR in OS, where eIF2α phosphorylation regulates BACE1 protein expression.
© 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22306812     DOI: 10.1016/j.bbadis.2012.01.009

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  69 in total

Review 1.  The case for rejecting the amyloid cascade hypothesis.

Authors:  Karl Herrup
Journal:  Nat Neurosci       Date:  2015-06       Impact factor: 24.884

2.  Increased levels of cerebrospinal fluid JNK3 associated with amyloid pathology: links to cognitive decline.

Authors:  Sarah Gourmaud; Claire Paquet; Julien Dumurgier; Clarisse Pace; Constantin Bouras; Françoise Gray; Jean-Louis Laplanche; Eliane F Meurs; François Mouton-Liger; Jacques Hugon
Journal:  J Psychiatry Neurosci       Date:  2015-05       Impact factor: 6.186

Review 3.  The Integrated Stress Response and Phosphorylated Eukaryotic Initiation Factor 2α in Neurodegeneration.

Authors:  Sarah Bond; Claudia Lopez-Lloreda; Patrick J Gannon; Cagla Akay-Espinoza; Kelly L Jordan-Sciutto
Journal:  J Neuropathol Exp Neurol       Date:  2020-02-01       Impact factor: 3.685

Review 4.  ER-stress in Alzheimer's disease: turning the scale?

Authors:  Kristina Endres; Sven Reinhardt
Journal:  Am J Neurodegener Dis       Date:  2013-11-29

5.  HIV Protease Inhibitors Alter Amyloid Precursor Protein Processing via β-Site Amyloid Precursor Protein Cleaving Enzyme-1 Translational Up-Regulation.

Authors:  Patrick J Gannon; Cagla Akay-Espinoza; Alan C Yee; Lisa A Briand; Michelle A Erickson; Benjamin B Gelman; Yan Gao; Norman J Haughey; M Christine Zink; Janice E Clements; Nicholas S Kim; Gabriel Van De Walle; Brigid K Jensen; Robert Vassar; R Christopher Pierce; Alexander J Gill; Dennis L Kolson; J Alan Diehl; Joseph L Mankowski; Kelly L Jordan-Sciutto
Journal:  Am J Pathol       Date:  2017-01       Impact factor: 4.307

6.  Bacopa monnieri prevents colchicine-induced dementia by anti-inflammatory action.

Authors:  Neetu Saini; Devinder Singh; Rajat Sandhir
Journal:  Metab Brain Dis       Date:  2019-01-02       Impact factor: 3.584

7.  Sevoflurane-Induced Endoplasmic Reticulum Stress Contributes to Neuroapoptosis and BACE-1 Expression in the Developing Brain: The Role of eIF2α.

Authors:  Bin Liu; Junming Xia; Yali Chen; Jun Zhang
Journal:  Neurotox Res       Date:  2016-09-28       Impact factor: 3.911

8.  Arctigenin effectively ameliorates memory impairment in Alzheimer's disease model mice targeting both β-amyloid production and clearance.

Authors:  Zhiyuan Zhu; Jianming Yan; Wei Jiang; Xin-gang Yao; Jing Chen; Lili Chen; Chenjing Li; Lihong Hu; Hualiang Jiang; Xu Shen
Journal:  J Neurosci       Date:  2013-08-07       Impact factor: 6.167

9.  PERK mediates eIF2α phosphorylation responsible for BACE1 elevation, CREB dysfunction and neurodegeneration in a mouse model of Alzheimer's disease.

Authors:  Latha Devi; Masuo Ohno
Journal:  Neurobiol Aging       Date:  2014-05-02       Impact factor: 4.673

Review 10.  Early Life Stress and Epigenetics in Late-onset Alzheimer's Dementia: A Systematic Review.

Authors:  Erwin Lemche
Journal:  Curr Genomics       Date:  2018-11       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.